NCT02161640

Brief Summary

Inflammatory Bowel Diseases (IBD) is a group of relapsing and remitting gut inflammatory conditions acquired due to genetic susceptibility and/or environmental triggers. The disease manifestations are being increasingly seen in young children and the life-long debilitation has a severe effect on quality of life. Limited evidence suggests, although rare, in some young IBD individuals vascular complications may ensue. This leads to increased risk of vascular problems such as thrombosis, arterial disease and stroke. In the present project we aim to study and highlight potential vascular changes in young Inflammatory Bowel Disease (IBD) patients and compare these changes with age and gender matched controls. Vasculature will be measured in multiple ways including blood analysis in the laboratory and non-invasive, physiological measures of arterial health (e.g. ultrasound arterial scan). Our overall goal is to identify biomarkers indicative of increased risk of vascular dysfunction as this will open new avenues for early therapeutic intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
63

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2014

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 10, 2014

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 12, 2014

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

February 23, 2017

Status Verified

February 1, 2017

Enrollment Period

2.2 years

First QC Date

June 10, 2014

Last Update Submit

February 22, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Carotid-Femoral Pulse Wave Velocity (PWV)

    Pulse wave velocity is a measure of arterial stiffness, and correlates with cardiovascular events and all-cause mortality.

    Once, upon recruitment

Secondary Outcomes (16)

  • Plasma Microparticle (MP) number

    Once, upon recruitment

  • Carotid Intima Media Thickness

    Once, upon recruitment

  • Plasma Microparticle (MP) pro-thrombotic potential

    Once, upon recruitment

  • Circulating endothelial cells (CEC)s enumeration

    Once, upon recruitment

  • Plasma C-reactive protein (CRP) level

    Once, upon recruitment

  • +11 more secondary outcomes

Study Arms (2)

Control

Age/sex matched control participants, not suffering from inflammatory bowel disease or any other chronic inflammatory disease

Inflammatory Bowel Disease

Patients with active or remissive inflammatory bowel disease

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients will be identified by the Clinical Nurse Specialists (CNS's) for Inflammatory Bowel Disease (IBD), on-call Gastroenterology registrars and consultants as well as the Pre-admission Nurses (PAN) within Great Ormond Street Hospital (GOSH). The lead consultants for IBD would also alert us of suitable patients for the study, as well as any suitable patients attending their regular gastroenterology clinics.

You may qualify if:

  • Clinical diagnosis of Inflammatory bowel disease (IBD arm)
  • Aged between 8 years and 18 years at recruitment (both arms)

You may not qualify if:

  • Clinical diagnosis of Inflammatory Bowel Disease (Control arm)
  • Diagnosis of any other chronic inflammatory condition

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Great Ormond Street Hospital

London, London, WC1N 3JH, United Kingdom

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Platelet poor plasma (PPP)

MeSH Terms

Conditions

Inflammatory Bowel DiseasesCrohn DiseaseColitis, Ulcerative

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesIntestinal DiseasesColitisColonic Diseases

Study Officials

  • James Bonner, BSc

    University College, London

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2014

First Posted

June 12, 2014

Study Start

September 1, 2014

Primary Completion

November 1, 2016

Study Completion

January 1, 2017

Last Updated

February 23, 2017

Record last verified: 2017-02

Locations